New research led by scientists at VCU Massey Comprehensive Cancer Center suggests that a class of drugs known as MCL-1 (myeloid leukemia cell-1) inhibitors interact with a type of kinase inhibitor ...

Aug. 13, 2025 12:15 PM ETAllurion Technologies Inc. (ALUR) Stock, ALUR.WS StockAI-Generated Earnings Calls Insights ...

・Crescent Biopharma is partnering with the Chinese firm Kelun-Biotech to expand its oncology drug pipeline and accelerate its combination strategy. ・The company also announced a $185 million private ...

St. Jude Children's Research Hospital scientists have identified a promising combination approach to treat a rare but catastrophic pediatric brain cancer called atypical teratoid rhabdoid tumor (ATRT) ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. Adding immunotherapy to a new type of inhibitor ...

Pelabresib plus Jakafi significantly reduced spleen volume and improved symptoms in myelofibrosis patients compared to Jakafi alone, with sustained benefits at 96 weeks. The combination therapy showed ...